"Moderne Hochleistungsmedizin mit Tradition im grünen Berliner Südwesten: Drei renommierte und deutschlandweit bekannte Fachkliniken, Lungenklinik Heckeshorn, Oskar-Helene-Heim, Behring-Krankenhaus, vereinen im heutigen Helios Klinikum Emil von Behring mit 14 Fachabteilungen, drei Instituten und zahlreichen Spezialzentren modernste medizinische Versorgung für Kinder und Erwachsene"

During the past decade, Helios Klinikum Emil Von Behring conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 15 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 10 clinical trials were completed. i.e. 90.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Helios Klinikum Emil Von Behring" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Actelion" with 3 trials sponsored, "Celgene" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Helios Klinikum Emil Von Behring" #1 collaborator was "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator, "BeiGene" with 1 trials as a collaborator, "CAPNETZ Stiftung" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator and "Coordinating Centre for Clinical Trials, Charité" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Helios Klinikum Emil Von Behring" are "Carcinoma, Non-Small-Cell Lung" (7 trials), "Idiopathic Pulmonary Fibrosis" (6 trials), "Lung Diseases" (2 trials), "Non-Squamous Non-Small Cell Lung Cancer" (2 trials) and "ALK-positive Advanced NSCLC" (1 trials). Many other conditions were trialed in "Helios Klinikum Emil Von Behring" in a lesser frequency.

Most popular intervention types in "Helios Klinikum Emil Von Behring" are "Drug" (36 trials), "Other" (3 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Carboplatin" (6 trials), "Cisplatin" (6 trials), "Pemetrexed" (6 trials) and "Atezolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Helios Klinikum Emil Von Behring" are 41 trials for "All" genders.

Currently, there are NaN active trials in "Helios Klinikum Emil Von Behring". undefined are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Helios Klinikum Emil Von Behring, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Helios Klinikum Emil Von Behring, 5 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

Helios Klinikum Emil Von Behring has several departments that took part in Clinical trials: "HELIOS Klinikum Emil von Behring Klinik f.Pneumologie Onkologie u.Infektiologie" - 3 trials